These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8121613)

  • 41. Role of metabotropic glutamate (ACPD) receptors at the parallel fiber-Purkinje cell synapse.
    Glaum SR; Slater NT; Rossi DJ; Miller RJ
    J Neurophysiol; 1992 Oct; 68(4):1453-62. PubMed ID: 1432092
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacological antagonism of the actions of group II and III mGluR agonists in the lateral perforant path of rat hippocampal slices.
    Bushell TJ; Jane DE; Tse HW; Watkins JC; Garthwaite J; Collingridge GL
    Br J Pharmacol; 1996 Apr; 117(7):1457-62. PubMed ID: 8730739
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Receptor subtypes linked to metabotropic glutamate receptor agonist-mediated limbic seizures in mice.
    Tizzano JP; Griffey KI; Schoepp DD
    Ann N Y Acad Sci; 1995 Sep; 765():230-5; discussion 248. PubMed ID: 7486609
    [No Abstract]   [Full Text] [Related]  

  • 44. Metabotropic glutamate receptors modulate synaptic transmission in the perforant path: pharmacology and localization of two distinct receptors.
    Dietrich D; Beck H; Kral T; Clusmann H; Elger CE; Schramm J
    Brain Res; 1997 Sep; 767(2):220-7. PubMed ID: 9367251
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Membrane potential and intracellular Ca2+ oscillations activated by mGluRs in hippocampal stratum oriens/alveus interneurons.
    Woodhall G; Gee CE; Robitaille R; Lacaille JC
    J Neurophysiol; 1999 Jan; 81(1):371-82. PubMed ID: 9914296
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Metabotropic glutamate receptor agonists reduce glutamate release from cultured astrocytes.
    Ye ZC; Sontheimer H
    Glia; 1999 Feb; 25(3):270-81. PubMed ID: 9932873
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Metabotropic glutamate receptor-mediated inhibition and excitation of substantia nigra dopamine neurons.
    Meltzer LT; Serpa KA; Christoffersen CL
    Synapse; 1997 Jun; 26(2):184-93. PubMed ID: 9131777
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Actions of agonists of metabotropic glutamate receptors on synaptic transmission and transmitter release in the olfactory cortex.
    Collins GG
    Br J Pharmacol; 1993 Feb; 108(2):422-30. PubMed ID: 7680593
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Trans-ACPD, a metabotropic receptor agonist, produces calcium mobilization and an inward current in cultured cerebellar Purkinje neurons.
    Linden DJ; Smeyne M; Connor JA
    J Neurophysiol; 1994 May; 71(5):1992-8. PubMed ID: 8064363
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A metabotropic glutamate receptor agonist regulates neurotrophin messenger RNA in rat forebrain.
    Murray KD; Wood PL; Rosasco C; Isackson PJ
    Neuroscience; 1996 Feb; 70(3):617-30. PubMed ID: 9045076
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synthesis and biology of the conformationally restricted ACPD analogue, 2-aminobicyclo[2.1.1]hexane-2,5-dicarboxylic acid-I, a potent mGluR agonist.
    Kozikowski AP; Steensma D; Araldi GL; Tückmantel W; Wang S; Pshenichkin S; Surina E; Wroblewski JT
    J Med Chem; 1998 May; 41(10):1641-50. PubMed ID: 9572889
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacological characterization of 1-aminoindan-1,5-dicarboxylic acid, a potent mGluR1 antagonist.
    Moroni F; Lombardi G; Thomsen C; Leonardi P; Attucci S; Peruginelli F; Torregrossa SA; Pellegrini-Giampietro DE; Luneia R; Pellicciari R
    J Pharmacol Exp Ther; 1997 May; 281(2):721-9. PubMed ID: 9152378
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterization of metabotropic glutamate receptor-mediated nitric oxide production in vivo.
    Bhardwaj A; Northington FJ; Martin LJ; Hanley DF; Traystman RJ; Koehler RC
    J Cereb Blood Flow Metab; 1997 Feb; 17(2):153-60. PubMed ID: 9040494
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Roles of metabotropic glutamate receptor subtypes in modulation of pentylenetetrazole-induced seizure activity in mice.
    Thomsen C; Dalby NO
    Neuropharmacology; 1998 Dec; 37(12):1465-73. PubMed ID: 9886669
    [TBL] [Abstract][Full Text] [Related]  

  • 55. New analogues of ACPD with selective activity for group II metabotropic glutamate receptors.
    Bräuner-Osborne H; Madsen U; Mikiciuk-Olasik E; Curry K
    Eur J Pharmacol; 1997 Aug; 332(3):327-31. PubMed ID: 9300268
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Both enantiomers of 1-aminocyclopentyl-1,3-dicarboxylate are full agonists of metabotropic glutamate receptors coupled to phospholipase C.
    Manzoni O; Prezeau L; Rassendren FA; Sladeczek F; Curry K; Bockaert J
    Mol Pharmacol; 1992 Aug; 42(2):322-7. PubMed ID: 1381045
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Acamprosate inhibits the binding and neurotoxic effects of trans-ACPD, suggesting a novel site of action at metabotropic glutamate receptors.
    Harris BR; Prendergast MA; Gibson DA; Rogers DT; Blanchard JA; Holley RC; Fu MC; Hart SR; Pedigo NW; Littleton JM
    Alcohol Clin Exp Res; 2002 Dec; 26(12):1779-93. PubMed ID: 12500101
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In vitro and in vivo pharmacology of trans- and cis-(+-)-1-amino-1,3-cyclopentanedicarboxylic acid: dissociation of metabotropic and ionotropic excitatory amino acid receptor effects.
    Schoepp DD; Johnson BG; Salhoff CR; McDonald JW; Johnston MV
    J Neurochem; 1991 May; 56(5):1789-96. PubMed ID: 1849553
    [TBL] [Abstract][Full Text] [Related]  

  • 59. 1S,3R-ACPD has cataleptogenic effects and reverses MK-801-, and less pronounced, D,L-amphetamine-induced locomotion.
    Kronthaler UO; Schmidt WJ
    Eur J Pharmacol; 1996 Dec; 316(2-3):129-36. PubMed ID: 8982678
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effects of the metabotropic glutamate receptor agonist 1S,3R-ACPD on neurones in the rat primary somatosensory cortex in vivo.
    Taylor KE; Cahusac PM
    Neuropharmacology; 1994 Jan; 33(1):103-8. PubMed ID: 8183433
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.